BR100 Decreased By (-0.27%)
BR30 Decreased By (-0.07%)
KSE100 Decreased By (-0.18%)
KSE30 Decreased By (-0.26%)
AGHA 7.75 Decreased By ▼ -0.06 (-0.77%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.88 Increased By ▲ 0.38 (0.66%)
BOP 34.13 Increased By ▲ 0.10 (0.29%)
CNERGY 10.06 Increased By ▲ 0.10 (1%)
CSIL 5.35 Increased By ▲ 0.04 (0.75%)
FCCL 54.65 Decreased By ▼ -0.05 (-0.09%)
FFL 16.62 Decreased By ▼ -0.07 (-0.42%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 7.28 Decreased By ▼ -0.12 (-1.62%)
KOSM 5.80 Increased By ▲ 0.03 (0.52%)
LOTCHEM 29.37 Increased By ▲ 0.05 (0.17%)
MLCF 93.75 Decreased By ▼ -0.61 (-0.65%)
NBP 202.00 Decreased By ▼ -1.05 (-0.52%)
NCPL 57.00 No Change ▼ 0.00 (0%)
NPL 67.88 Increased By ▲ 0.18 (0.27%)
OGDC 316.85 Increased By ▲ 1.01 (0.32%)
PACE 10.65 Increased By ▲ 0.01 (0.09%)
PAEL 43.02 Decreased By ▼ -0.18 (-0.42%)
PIBTL 16.67 Decreased By ▼ -0.07 (-0.42%)
PPL 219.48 Decreased By ▼ -0.30 (-0.14%)
PRL 50.50 Increased By ▲ 1.31 (2.66%)
PTC 70.70 Increased By ▲ 0.17 (0.24%)
SSGC 27.80 Decreased By ▼ -0.45 (-1.59%)
TBL 9.75 Decreased By ▼ -0.11 (-1.12%)
TELE 8.70 Decreased By ▼ -0.09 (-1.02%)
TPL 18.30 Increased By ▲ 0.06 (0.33%)
TPLP 13.52 Increased By ▲ 0.25 (1.88%)
TREET 22.64 Decreased By ▼ -0.08 (-0.35%)
TRG 60.05 Decreased By ▼ -0.09 (-0.15%)
By

UK’s FTSE 100 edged higher at open on Tuesday, led by mining and healthcare stocks, while shares of Ocado jumped after the online supermarket group kept its full-year guidance unchanged.

By 0716 GMT, the blue-chip FTSE 100 added 0.1%, while the more domestically-focussed FTSE 250 midcap index rose 0.2%.

Miners of both industrial and precious metals rose 0.5% each, as most metal prices appreciated on a softer dollar.

Ocado jumped 7.3% after the online supermarket and technology group kept its financial guidance for the year as it reported a return to underlying profit in its first half.

UK’s FTSE 100 falls as weak China data hits commodity stocks

AstraZeneca rose 0.8% after the US Food and Drug Administration (FDA) said it had approved the drugmaker and partner Sanofi’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

Darktrace jumped 20.1% after the cyber-security company said a review by auditing firm EY showed “a number of areas” where its systems, processes or controls could be improved, but added that the report will not impact its previous financial statements.

Comments

Comments are closed for this article.